Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb;46(2):204-213.
doi: 10.1002/clc.23962. Epub 2022 Dec 25.

Effect of nonobstructive coronary stenosis on coronary microvascular dysfunction and long-term outcomes in patients with INOCA

Ayman A Mohammed  1   2 , Hengbin Zhang  1 , Fuad A Abdu  1 , Lu Liu  1 , Shekhar Singh  1 , Xian Lv  1 , Tingting Shi  1 , Redhwan M Mareai  1 , Abdul-Quddus Mohammed  1 , Guoqing Yin  1 , Wen Zhang  1 , Yawei Xu  1 , Wenliang Che  1   3
Affiliations

Effect of nonobstructive coronary stenosis on coronary microvascular dysfunction and long-term outcomes in patients with INOCA

Ayman A Mohammed et al. Clin Cardiol. 2023 Feb.

Abstract

Background: Ischemic pain with no-obstructive coronary artery (INOCA) is clinically significant and defined by nonobstructive coronary stenosis <50%. Coronary microvascular dysfunction (CMD) is a relevant cause associated with adverse outcomes.

Objectives: Investigated the effect of no-stenosis (0% stenosis) and non-obstructive (0% < stenosis < 50%) on the prognostic impact of CMD in INOCA.

Method: A retrospective study assessed the coronary microvascular function in 151 INOCA patients who underwent invasive angiography by the coronary angiography-derived index of microcirculation-resistance (caIMR). CZT-SPECT was performed to evaluate myocardial perfusion imaging (MPI) abnormalities. Chi-square test/Fisher exact test, Student t-test, Kaplan-Meier curve, and Uni-multivariable Cox proportional models were used for analysis. Clinical outcomes were major adverse cardiovascular events (MACE) during a median follow-up of 35 months.

Result: No-stenosis was present in 71 (47%) INOCA patients, and 80 (53%) were with nonobstructive. CMD (caIMR ≥ 25) was more prevalent in patients with no-stenosis than nonobstructive (76.1% vs. 48.8%, p = .001), along with abnormal MPI (39.4% vs. 22.5%, p = .024). The MACE rates were not different between no-stenosis and nonobstructive stenosis. CMD showed an increased risk of MACE for all INOCA. No-stenosis with CMD had the worst prognosis. Cox regression analysis identified CMD and abnormal MPI as predictors of MACE in all INOCA and patients with no-stenosis. However, no-stenosis and nonobstructive stenosis were not predictors of MACE in INOCA.

Conclusion: CMD was more frequently present in INOCA with no-stenosis. However, there was no difference in long-term clinical outcomes between no-stenosis and nonobstructive stenosis. CMD could independently predict poor outcomes in INOCA, particularly in patients with no-stenosis.

Keywords: CMD; INOCA; nonobstructive coronary stenosis; prognosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Kaplan–Meier curves for free survival from MACE in INOCA patients. (A) Kaplan–Meier curves for free survival from MACE stratified by macrovascular anatomy. (B) Kaplan–Meier curves for free survival from MACE stratified by microvascular dysfunction. (C) Kaplan–Meier curves for free survival from MACE stratified by macrovascular anatomy and microvascular dysfunction. CMD, coronary microvascular dysfunction; INOCA, ischemia with no obstructive coronary arteries; MACE, major adverse cardiac events.
Figure 2
Figure 2
Kaplan–Meier curves for free survival from MACE among patients with no‐stenosis and nonobstructive stenosis by CMD. (A) Kaplan–Meier curve among no‐stenosis patients. (B) Kaplan–Meier curve among nonobstructive stenosis. CMD, coronary microvascular dysfunction; MACE, major adverse cardiac events.
See this image and copyright information in PMC

References

    1. Wang H, Naghavi M, Allen C, et al. Global, regional, and national life expectancy, all‐cause mortality, and cause‐specific mortality for 249 causes of death, 1980‐2015: a systematic analysis for the global burden of disease study 2015. The Lancet. 2016;388(10053):1459‐1544. - PMC - PubMed
    1. Knuuti J, Wijns W, Saraste A, et al. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41(3):407‐477. - PubMed
    1. Reeh J, Therming CB, Heitmann M, et al. Prediction of obstructive coronary artery disease and prognosis in patients with suspected stable angina. Eur Heart J. 2019;40(18):1426‐1435. - PubMed
    1. Wang ZJ, Zhang LL, Elmariah S, Han HY, Zhou YJ. Prevalence and prognosis of nonobstructive coronary artery disease in patients undergoing coronary angiography or coronary computed tomography angiography. Mayo Clin Proc. 2017;92(3):329‐346. - PubMed
    1. Jespersen L, Hvelplund A, Abildstrom SZ, et al. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. Eur Heart J. 2012;33(6):734‐744. - PubMed

LinkOut - more resources